Skip to main content
. 2016 Jul 18;9(7):955–966. doi: 10.18240/ijo.2016.07.04

Figure 7. Intravitreous injection of αA-crystallin decreased the expression of neurocan in the crush site at 14d after ONC.

Figure 7

Immunofluorescence staining showed the neurocan (green) expression in the crush site following ONC in the ONC injury (injury only) (A-C, and C zoomed image D), PBS-treated ONC injury (PBS injection) (E-G, and G zoomed image H) and αA-crystallin-treated ONC injury groups (α-A injection) (I-K, and K zoomed image L). The arrows indicate neurocan-positive labeling. cr: The middle of crush site. The arrows indicate neurocan-positive labeling.